Search Results

There are 14727 results for: content related to: Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis

  1. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  2. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  3. Tocilizumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Saba Beg and Maria Angeles Lopez-Olivo

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD008331.pub2

  4. You have full text access to this OnlineOpen article
    Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases

    FEBS Letters

    Volume 585, Issue 23, December 01, 2011, Pages: 3699–3709, Toshio Tanaka, Masashi Narazaki and Tadamitsu Kishimoto

    Version of Record online : 21 MAR 2011, DOI: 10.1016/j.febslet.2011.03.023

  5. You have free access to this content
    Exposure-Exposure Relationship of Tocilizumab, an Anti–IL-6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 151–159, Micha Levi, Susan Grange and Nicolas Frey

    Version of Record online : 22 FEB 2013, DOI: 10.1177/0091270012437585

  6. Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 50, Issue 7, July 2010, Pages: 754–766, Dr Nicolas Frey, Dr Susan Grange and Dr Thasia Woodworth

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009350623

  7. You have free access to this content
    Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

    Arthritis & Rheumatism

    Volume 63, Issue 3, March 2011, Pages: 609–621, Joel M. Kremer, Ricardo Blanco, Marek Brzosko, Ruben Burgos-Vargas, Anne-Marie Halland, Emma Vernon, Petra Ambs and Roy Fleischmann

    Version of Record online : 25 FEB 2011, DOI: 10.1002/art.30158

  8. You have free access to this content
    Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis

    Arthritis Care & Research

    Volume 65, Issue 5, May 2013, Pages: 745–752, Yukiko Kimura, Jennifer E. Weiss, Kathryn L. Haroldson, Tzielan Lee, Marilynn Punaro, Sheila Oliveira, Egla Rabinovich, Meredith Riebschleger, Jordi Antón, Peter R. Blier, Valeria Gerloni, Melissa M. Hazen, Elizabeth Kessler, Karen Onel, Murray H. Passo, Robert M. Rennebohm, Carol A. Wallace, Patricia Woo, Nico Wulffraat and The Childhood Arthritis Rheumatology Research Alliance Carra Net Investigators

    Version of Record online : 23 APR 2013, DOI: 10.1002/acr.21889

  9. Disease–Drug–Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 5, May 2011, Pages: 735–740, C Schmitt, B Kuhn, X Zhang, AJ Kivitz and S Grange

    Version of Record online : 23 MAR 2011, DOI: 10.1038/clpt.2011.35

  10. You have full text access to this OnlineOpen article
    Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)

    The Journal of Clinical Pharmacology

    Volume 54, Issue 1, January 2014, Pages: 109–119, Shuji Ohta, Tomomi Tsuru, Kimio Terao, Seiji Mogi, Midori Suzaki, Eisuke Shono, Yoshimasa Ishida, Eriko Tarumi and Masato Imai

    Version of Record online : 12 OCT 2013, DOI: 10.1002/jcph.185

  11. You have free access to this content
    Interleukin-6 blockade in ocular inflammatory diseases

    Clinical & Experimental Immunology

    Volume 176, Issue 3, June 2014, Pages: 301–309, M. Mesquida, A. Leszczynska, V. Llorenç and A. Adán

    Version of Record online : 24 APR 2014, DOI: 10.1111/cei.12295

  12. Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer

    International Journal of Cancer

    Volume 137, Issue 5, 1 September 2015, Pages: 1035–1046, Freya A. Goumas, Reinhild Holmer, Jan-Hendrik Egberts, Artur Gontarewicz, Carola Heneweer, Ulf Geisen, Charlotte Hauser, Maria-Margarete Mende, Karen Legler, Christoph Röcken, Thomas Becker, Georg H. Waetzig, Stefan Rose-John and Holger Kalthoff

    Version of Record online : 29 JAN 2015, DOI: 10.1002/ijc.29445

  13. You have free access to this content
    Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

    Arthritis & Rheumatism

    Volume 54, Issue 9, September 2006, Pages: 2817–2829, R. N. Maini, P. C. Taylor, J. Szechinski, K. Pavelka, J. Bröll, G. Balint, P. Emery, F. Raemen, J. Petersen, J. Smolen, D. Thomson and T. Kishimoto

    Version of Record online : 31 AUG 2006, DOI: 10.1002/art.22033

  14. You have free access to this content
    Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

    Arthritis & Rheumatism

    Volume 58, Issue 10, October 2008, Pages: 2968–2980, Mark C. Genovese, James D. McKay, Evgeny L. Nasonov, Eduardo F. Mysler, Nilzio A. da Silva, Emma Alecock, Thasia Woodworth and Juan J. Gomez-Reino

    Version of Record online : 29 SEP 2008, DOI: 10.1002/art.23940

  15. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara J Maxwell, John K MacDonald, Graziella Filippini, Nicole Skoetz, Damian K Francis, Luciane C Lopes, Gordon H Guyatt, Jochen Schmitt, Loredana La Mantia, Tobias Weberschock, Juliana F Roos, Hendrik Siebert, Sarah Hershan, Chris Cameron, Michael PT Lunn, Peter Tugwell and Rachelle Buchbinder

    Published Online : 16 FEB 2011, DOI: 10.1002/14651858.CD008794.pub2

  16. Interleukin-6 as a Therapeutic Target in Candidate Inflammatory Diseases

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 4, April 2010, Pages: 483–487, N Nishimoto

    Version of Record online : 24 FEB 2010, DOI: 10.1038/clpt.2009.313

  17. Risk for Gastrointestinal Perforation among Rheumatoid Arthritis Patients receiving Tofacitinib, Tocilizumab, or other Biologics

    Arthritis & Rheumatology

    Accepted manuscript online: 23 MAY 2016, Fenglong Xie, Huifeng Yun, Sasha Bernatsky and Jeffrey R Curtis

    DOI: 10.1002/art.39761

  18. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study

    International Journal of Rheumatic Diseases

    Tristan Pascart, Peggy Philippe, Elodie Drumez, Xavier Deprez, Bernard Cortet, Alain Duhamel, Eric Houvenagel and René-Marc Flipo

    Version of Record online : 27 MAR 2016, DOI: 10.1111/1756-185X.12845

  19. You have free access to this content
    Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

    Arthritis & Rheumatism

    Volume 62, Issue 2, February 2010, Pages: 542–552, Gabor G. Illei, Yuko Shirota, Cheryl H. Yarboro, Jimmy Daruwalla, Edward Tackey, Kazuki Takada, Thomas Fleisher, James E. Balow and Peter E. Lipsky

    Version of Record online : 28 JAN 2010, DOI: 10.1002/art.27221

  20. You have free access to this content
    2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications

    Arthritis Care & Research

    Volume 65, Issue 10, October 2013, Pages: 1551–1563, Sarah Ringold, Pamela F. Weiss, Timothy Beukelman, Esi Morgan DeWitt, Norman T. Ilowite, Yukiko Kimura, Ronald M. Laxer, Daniel J. Lovell, Peter A. Nigrovic, Angela Byun Robinson and Richard K. Vehe

    Version of Record online : 24 SEP 2013, DOI: 10.1002/acr.22087